Authors
Karlijn de Joode, Daphne W Dumoulin, Jolien Tol, Hans M Westgeest, Laurens V Beerepoot, Franchette WPJ van den Berkmortel, Pim GNJ Mutsaers, Nico GJ van Diemen, Otto J Visser, Esther Oomen-de Hoop, Haiko J Bloemendal, Hanneke WM van Laarhoven, Lizza EL Hendriks, John BAG Haanen, Elisabeth GE de Vries, Anne-Marie C Dingemans, Astrid AM van der Veldt, CJ van Loenhout, CH van der Leest, A Becker-Commissaris, JSW Borgers, F Terhegggen, BEEM van den Borne, LJC van Warmerdam, L van Leeuwen, FS van der Meer, MA Tiemessen, DM van Diepen, Y Klaver, AP Hamberg, EJ Libourel, L Strobbe, M Cloos, EJ Geraedts, JC Drooger, R Heller, JWB de Groot, JA Stigt, VJAA Nuij, CCM Pitz, Marije Slingerland, FJ Borm, BCM Haberkorn, SC van't Westeinde, MJB Aarts, JWG van Putten, M Youssef, GA Cirkel, GJM Herder, CR van Rooijen, E Citgez, NP Barlo, BMJ Scholtes, RHT Koornstra, NJM Claessens, LM Faber, CH Rikers, RAW van de Wetering, GL Veurink, BW Bouter, I Houtenbos, MPL Bard, KH Herbschleb, EA Kastelijn, P Brocken, G Douma, M Jalving, TJN Hiltermann, OCJ Schuurbiers-Siebers, KPM Suijkerbuijk, ASR van Lindert, AJ van de Wouw, VEM van den Boogaart, SD Bakker, E Looysen, AL Peerdeman, WK de Jong, EJM Siemerink, AJ Staal, B Franken, WH van Geffen, GP Bootsma
Publication date
2020/12/1
Journal
European Journal of Cancer
Volume
141
Pages
171-184
Publisher
Pergamon
Description
Aim of the study
Patients with cancer might have an increased risk for severe outcome of coronavirus disease 2019 (COVID-19). To identify risk factors associated with a worse outcome of COVID-19, a nationwide registry was developed for patients with cancer and COVID-19.
Methods
This observational cohort study has been designed as a quality of care registry and is executed by the Dutch Oncology COVID-19 Consortium (DOCC), a nationwide collaboration of oncology physicians in the Netherlands. A questionnaire has been developed to collect pseudonymised patient data on patients' characteristics, cancer diagnosis and treatment. All patients with COVID-19 and a cancer diagnosis or treatment in the past 5 years are eligible.
Results
Between March 27th and May 4th, 442 patients were registered. For this first analysis, 351 patients were included of whom 114 patients died. In multivariable analyses, age ≥65 …
Scholar articles
K de Joode, DW Dumoulin, J Tol, HM Westgeest… - European Journal of Cancer, 2020